Walleye Trading
FRTX

Walleye Trading’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Walleye Trading’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-515
Closed -$222K – 5476
2018
Q3 		$222K Buy
+515
New +$217K ﹤0.01% 3686

Other funds holding FRTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Walleye Trading's FRTX Position: Q4 2018 in Review

Walleye Trading sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2018, closing a stake of 515 shares — an estimated $222K sold.

Walleye Trading first reported a position in FRTX in Q3 2018 and held it in 1 quarter. The position peaked at $222K in Q3 2018. 27 funds tracked by Wall St. Rank hold FRTX as of Q4 2018.

  • Walleye Trading reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Walleye Trading sold 515 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $222K.
  • Walleye Trading first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Walleye Trading's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $222K in Q3 2018.
  • 27 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.